Le « En cas de Covid prenez du Doliprane et quand vous aurez du mal à respirer faites le 15 », c’est fini. L’émiettement des associations de médecins, de para-médicaux et de consommateurs en colère, c’est fini aussi. « Laissons les médecins prescrire » a tendu la main et l’énorme RéinfoCovid du Dr Louis Fouché, la très belle AIMSIB, la méridionnale « Azi-thro d’hospitalisations », la grande Bonsens comme tant d’autres associations ont décidé de se fédérer et de réfléchir ensemble aux solutions alternatives à proposer face à la situation sanitaire actuelle. Traitements préventifs en fonction des niveaux de risques, traitements curatifs selon les situations cliniques, problématique vaccinale, données d’épidémiologie nationale, réclamation d’un 49.2 à l’Assemblée Nationale, tout y est, diffusez partout, bon visionnage et bonne lecture.

1- La conférence de presse Coordination Santé Libre du 09/01/2021

00:00: Dr Violaine Guerin, Introduction
04:10: Dr Claire Delval, Dr Claude Escarguel,  traitement préventif, traitement curatif
14:25: Dr Vincent Reliquet, Vaccination anti-Covid-19 à ce jour
24:50: Dr Martine Wonner, résolution européenne, aucune obligation vaccinale
30:40: Dr Gérard Guillaume, la cellule chiffre
41:36: Intérêt du maillage territorial Réinfocovid
48:05: Analyse du Dr Martine Wonner, Députée, « le 49-2 »
55:00: Dr Violaine Guerin, sport sur ordonnance
59:45: Mr Yvan Rioufol, journaliste, questions
1:11:12: Vaccinations obligatoire des voyageurs
1:13:47 Mr Xavier Azalbert, questions
1:18:52: Mr Yvan Rioufol, questions

2- Traitements préventifs de la Covid-19 en fonction des niveaux de risques

Collectif Coordination Santé Libre, 31/01/2021

 

Traitements curatifs précoces en fonction des stades de gravité

Collectif Coordination Santé Libre, 31/01/2021

 

Collectif Coordination Santé Libre, 31/01/2021

 

Notes et sources:
(1) Laird E, Rhodes JM, Kenny RA. Vitamin D and inflammation: potential implications for severity of Covid-19. Ir Med J, 2020, 113(5) : 81
(2) McCartney DM, Byrne D. Optimisation of vitamin D status for enhanced immunoprotection against Covid-19. Ir Med J, 2020, 113(4): 58
(3) Communiqué de l’Académie Nationale de Médecine : Vitamine D et Covid-19, 22 Mai 2020
https://www.academie-medecine.fr/wp-content/uploads/2020/05/Vitamine-D-et-Covid-19.pdf
(4) Wessels I, Rolles B, Rink L. The potential impact of zinc supplementation on COVID-19 pathogenesis. Front Immunol, 2020, 11, 1712 – doi: 10.3389/fimmu.2020.01712
(5) Hunter J, Arentz S, Goldenberg J et al. Rapid review protocol: zinc for the prevention or treatment of COVID-19 and other coronavirus-related respiratory tract infections. Integr Med
Res, 2020, 9(3), 100457
(6) Colunga Biancatelli RM, Berrill M, Catravas JD et al. Quercetin and vitamin C: An Experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease
(COVID-19), Front Immunol, 2020, 11, 1451 – doi: 10.3389/fimmu.2020.01451
(7) Colunga Biancatelli RM, Berrill M, Marik PE. The antiviral properties of vitamin C. Expert review of Anti-infective Therapy, 2020, 18(2), 99-101 – doi: 10.1080/14787210.2020.1706483
(8) Debojyoti D, Abhishek M. Gut microbiota and Covid-19- possible link and implications. Virus Res, 2020, 285, 198018 – doi: 10.1016/j.virusres.2020.198018
(9) Shinde T, Hansbro PM, Sohal SS et al. Microbiota modulating nutritional approaches to countering the effects of viral respiratory infections including SARS-CoV-2 through promoting
metabolic and immune fitness with probiotics and plant bioactives. Microorganisms, 2020, 8, 921 – doi: 10.3390/microorganisms8060921
(10) Wilke J, Mohr L, Tenforde AS et al. Activity and health during the SARS-CoV2 pandemic (ASAP): study protocol for a multi-national network trial. Front Med (Lausanne), 2020, 7, 302 –
doi: 10.3389/fmed.2020.00302
(11) Da Silveira MP, Da Silva Fagundes KK, Bizuti MR, et al. Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature. Clin Exp
Med, 2020, 1-14 – doi: 10.1007/s10238-020-00650-3
(12) Galmés S, Serra F, Palou A. Current state of evidence: influence of nutritional and nutrigenetic factors on immunity in the COVID-19 pandemic framework. Nutrients, 2020, 12(9) : 2738
(13) Calder PC. Nutrition, immunity and COVID-19. BMJ Nutrition Prev Health, 2020, 3(1)
(14) Dos Santos RM. Isolation, social stress, low socioeconomic status and its relationship to immune response in Covid-19 pandemic context. Brain Behav Immunity Health, 2020, 7, 100103
(15) Khalil AN, Rahaf RE. (2020). Relationship between stress, immune system, and pandemics of Coronaviruses’ COVID19: updates narrative review. Eur J Mol Clin Med, 2020, 7(10)
(16) Radulesco T, Lechien JR, Saussez S et al. Safety and impact of nasal lavages during viral infections such as SARS-CoV-2, Ear Nose Throat J, 2020, 145561320950491 –
doi: 10.1177/0145561320950491
(17) Nadjib BM. Effective antiviral activity of essential oils and their characteristic terpenes against coronaviruses: an update. J Pharmacol Clin Toxicol, 2020, 8(1), 1138
(18) Kembuan GJ, Lie W, Tumimomor AH. Potential usage of immune-modulating supplements of the Echinacea genus for COVID-19 infection. Int J Med Rev Case Rep, 2020, 4(1)
(19) Signer J, Jonsdottir HR, Albrich WC et al. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E
and SARS-CoV-2. Virol J, 2020, 17, 136
(20) Aucoin M, Cooley K, Saunders PR et al. Effect of quercetin on the prevention or treatment of Covid19 and other respiratory tract infections in humans: a rapid review. Adv Integr Med,
2020, 7(4), 247-251
(21) Derosa G, Maffioli P, d’Angelo A et al. A role for quercetin in coronavirus disease 2019. Phytother Res, 2020, oct 9:10,1002/ptr.6887 – doi: 10.1002/ptr.6887
(22) Shouman W. Prophylactic ivermectin in COVID-19 contacts. Zagazig University (ClinicalTrials.gov; NCT04422561). https://clinicaltrials.gov/ct2/show/NCT04422561
(23) Hellwig MD, Maia A. A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin. Int J Antimicrob Agents, 2021, 57(1),106248 doi:
10.1016/j.ijantimicag.2020.106248
(24) Portmann-Baracco A, Bryce-Alberti M, Accinelli RA. Antiviral and anti-inflammatory properties of ivermectin and its potential use in Covid-19, Arch Bronconeumol, 2020, 56(12), 831
doi: 10.1016/j.arbr.2020.06.006
(25) Annweiler C, Souberbielle JC. Vitamin D supplementation and COVID-19: expert consensus and guidelines. Geriatr Psychol Neuropsychiatr Vieil, 2020 – doi: 10.1684/pnv.2020.0907
(26) Lepere P, Escarguel B, Yolartiran S et al. The role of macrolide antibiotics in the prevention of severe COVID-19 disease progression via the disruption of bacteria/virus co-operation. 2020
doi: 10.2139/ssrn.3712423
(27) Schwartz RA, Suskind RM. Azithromycin and COVID-19: prompt early use at first signs of this infection in adults and children, an approach worthy of consideration. Dermatol Ther,
2020, 33(4), e13785 doi: 10.1111/dth.13785
(28) Guérin V, Lévy P, Thomas JL et al. Azithromycin and hydroxychloroquine accelerate recovery of outpatients with mild/moderate COVID-19. Asian J Med Health, 2020, 18(7), 45-55
doi: 10.9734/ajmah/2020/v18i730224
(29) Lagier JC, Million M, Gautret P et al. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: a retrospective analysis.
Travel Med Infect Dis, 2020, 101791
doi: 10.1016/j.tmaid.2020.101791
(30) Arshad S, Kilgore P, Chaudhry ZS et al. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. Int J Infect Dis, 2020, 97, 396-403 doi:
10.1016/j.ijid.2020.06.099
(31) Hashim AH, Maulood MF, Rasheed AM et al. Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq. 2020
medRxiv 2020.10.26.20219345; doi: 10.1101/2020.10.26.20219345
(32) Song, JC, Wang, G, Zhang W et al. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Military Med Res, 2020, 7, 19
doi: 10.1186/s40779-020-00247-7
(33) Tang N, Bai H, Chen X et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost, 2020, 18(5),
1094-1099 doi: 10.1111/jth.14817
(34) Derosa G, Maffioli P, D’Angelo A et al. A role for quercetin in coronavirus disease 2019 (COVID-19). Phytother Res, 2020, 1–7
(35) Bastaminejad S, Bakhtiyari S. Quercetin and its relative therapeutic potential against COVID-19: a retrospective review and prospective overview. Curr Mol Med, 2020, 20, 1
doi: 10.2174/1566524020999200918150630
(36) Saiz-Rodríguez M, Peña T, Lázaro L et al. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the
course of the disease: a structured summary of a randomised controlled trial. Trials, 2020, 21, 632
(37) Koshak DAE, Koshak PEA. Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: a mini review of in silico studies. Curr Ther Res Clin Exp, 2020, 93:100602
doi: 10.1016/j.curtheres.2020.100602
(38) Siddiqui S, Upadhyay S, Ahmad R, Gupta A, Srivastava A, Trivedi A, Husain I, Ahmad B, Ahamed M, Khan MA. Virtual screening of phytoconstituents from miracle herb nigella sativa targeting
nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment. J Biomol Struct Dyn, 2020, 1-21
doi: 10.1080/07391102.2020.1852117
(39) Berretta AA, Silveira MAD, Cóndor Capcha JM et al. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease. Biomed Pharmacother. 2020, 131:110622
(40) Zhang B, Zhang K, Tang Q et al. Acupuncture for breathlessness in COVID-19: a protocol for systematic review and meta-analysis. Medicine (Baltimore), 2020, 99(27), e20701
doi: 10.1097/MD.0000000000020701
(41) Sun P, Zhou WS. Acupuncture in the treatment of COVID-19: an exploratory study. J Chin Med, 2020, 123
(42) Kalliantas D, Kallianta M, Karagianni CS. Homeopathy combat against coronavirus disease (Covid-19) [published online ahead of print, 2020 Jun 5]. Z Gesundh Wiss, 2020, 1-4
doi: 10.1007/s10389-020-01305-z
(43) Sardesai I, Grover J, Garg M et al. Short term home oxygen therapy for COVID-19 patients: the COVID-HOT algorithm. J Family Med Prim Care, 2020, 9 (7), 3209-3219

Auteur de l'article :

Lire tous les articles de

libero. Curabitur Lorem et, felis ipsum